Deucravacitinib in Hidradenitis Suppurativa: An Open Label Proof of Concept Study.

Pham J, Allan T, Guttman L, Frew JW

Open source

DOI
10.1016/j.jaad.2026.09.065
Published
2026 Sep 22
Container
Journal of the American Academy of Dermatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jaad.2026.09.065,
  title = {Deucravacitinib in Hidradenitis Suppurativa: An Open Label Proof of Concept Study.},
  author = {Pham J and Allan T and Guttman L and Frew JW},
  year = {2026},
  journal = {Journal of the American Academy of Dermatology},
  doi = {10.1016/j.jaad.2026.09.065},
  url = {https://doi.org/10.1016/j.jaad.2026.09.065}
}

RIS

TY  - JOUR
TI  - Deucravacitinib in Hidradenitis Suppurativa: An Open Label Proof of Concept Study.
AU  - Pham J
AU  - Allan T
AU  - Guttman L
AU  - Frew JW
PY  - 2026
JO  - Journal of the American Academy of Dermatology
DO  - 10.1016/j.jaad.2026.09.065
UR  - https://doi.org/10.1016/j.jaad.2026.09.065
ER  - 

APA

J, P., T, A., L, G., & JW, F. (2026). Deucravacitinib in Hidradenitis Suppurativa: An Open Label Proof of Concept Study.. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.09.065

Source records